# Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer

Source: https://onco.cc/trials/nct07665684/  
OnCo record `nct07665684` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial in pancreatic cancer, run by University Health Network, Toronto, not yet recruiting.

## Summary

Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer is a phase 1/2, interventional study registered as NCT07665684 by University Health Network, Toronto, with a registry enrolment figure of 67 participants, started 2026-07 and due to reach its primary completion in 2029-05. Interventions recorded: Samuraciclib + Gemcitabine & Nab-Paclitaxel. Conditions listed: Pancreas Ductal Adenocarcinoma; Pancreas Cancer, Metastatic; Pancreatic Adenocarcinoma Metastatic; Adenosquamous Carcinoma of the Pancreas; Mucinous Adenocarcinoma. Primary outcome: Frequencies of adverse events (AEs), as graded by CTCAE v6.0 and reported by dose level; Percentages of adverse events (AEs), as graded by CTCAE v6.0 and reported by dose level; Frequencies of dose-limiting toxicities reported by dose level. Pancreatic eligibility wording from the registry: "Known homologous recombination deficient pancreatic cancer, including germline or somatic BRCA1/2 or PALB2 mutations". Sites: Canada. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Also known as: SONIC
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07665684
- Phase: 1/2
- Setting: Phase Ib/II Study of Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer
- Sponsor: University Health Network, Toronto
- Enrolled: 67

## Sources

- ClinicalTrials.gov NCT07665684: https://clinicaltrials.gov/study/NCT07665684

## Connected records

- cancers: [BRCA or PALB2-mutant pancreatic ductal adenocarcinoma](https://onco.cc/cancers/brca-palb2-pdac/), [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07665684.json